Compilation of Rules and Regulations of the State of Georgia › Department 111 - RULES OF DEPARTMENT OF COMMUNITY HEALTH › Chapter 111-8 - HEALTHCARE FACILITY REGULATION › Subject 111-8-9 - BLOOD LABELING › Rule 111-8-9-.01 - Definitions

Current through Rules and Regulations filed through June 27, 2024
Unless a different meaning is required by the context, the
				  following terms as used in these rules and regulations shall have the meaning
				  hereinafter respectively ascribed to them:
(a) "Act" means "The Blood Labeling Act"
				(O.C.G.A. §
									31-24-1
et
				seq.
);
(b) "Person" means
				any individual, blood bank, clinical laboratory, hospital, firm, corporation or
				any other entity;
(c) "Department"
				means the Georgia Department of Community Health;
(d) "Board" means the Board of Community
				Health;
(e) "Clinical Laboratory"
				means a single facility for the biological, microbiological, serological,
				immunological, chemical, immunohematological, hematological, biophysical,
				cytological, pathological, or other examination of materials derived from the
				human body, for the diagnosis of, recommendation of treatment of, or for the
				purpose of providing for the diagnosis, prevention, or treatment of any disease
				or impairment of, or the assessment of the health of, man; the term "clinical
				laboratory" shall include blood banks which provide through their ownership or
				operation a system for the collection, processing, or storage of human blood
				and its component parts as well as tissue banks which store human or animal
				tissues designed to be used for medical purposes in human beings.
(f) "Director" means a person who is
				responsible for the administration of the technical and scientific operation of
				a clinical laboratory, including supervision of procedures for testing and the
				reporting of results;
(g) "Blood"
				means whole human blood, packed red blood cells, blood platelets, concentrated
				leukocytes, and blood plasma. It does not include blood derivatives
				manufactured or processed for industrial use.
(h) "Donation" means any transaction
				involving the person from whom blood is withdrawn, whether he presents himself
				for the withdrawal of blood on his own initiative or on the initiative of
				another person, in which he receives no consideration other than credit through
				blood assurance programs or other intangible benefits.
(i) "Purchase" means any transaction
				involving the person from whom blood is withdrawn, whether he presents himself
				for the withdrawal of blood on his own initiative or on the initiative of
				another person, in which he receives a monetary consideration in any form. Time
				off from work granted by an employer for the purpose of giving blood shall not
				be considered a direct monetary consideration.
(j) "Industrial use" means a use of blood in
				which the blood is modified by physical or chemical means to produce
				derivatives for therapeutic or pharmaceutic biologicals and laboratory reagents
				or controls.
(k) "Transfusion"
				means a use of blood in which the blood is administered to a human being for
				treatment of sickness or injury.
O.C.G.A. §§
										31-2-5,
				  31-2-7 and
				  31-24-1
et
				  seq.